Stock Code
688016.SH
Stock Code
688016.SH
Mr. Jonathan Chen, born in 1975, is an American national and holds a bachelor's degree in Economics and an honors bachelor degree in Biological Sciences from Stanford University. Jonathan served as vice president of Investment Banking at Credit Suisse, and senior vice president of Business Development and Financial Strategy at Angiotech Pharmaceuticals. Jonathan joined MicroPort® in 2012 as executive vice president of International Business and Investor Relations, and now serves as chief international business officer, chairman of the Intercontinental Cardiac Rhythm Management Committee, and a member of the Intercontinental Orthopedics Executive Committee at MicroPort®. Jonathan has been chairman of Endovastec™ since November 2023.
Mr. Jonathan Chen, born in 1975, is an American national and holds a bachelor's degree in Economics and an honors bachelor degree in Biological Sciences from Stanford University. Jonathan served as vice president of Investment Banking at Credit Suisse, and senior vice president of Business Development and Financial Strategy at Angiotech Pharmaceuticals. Jonathan joined MicroPort® in 2012 as executive vice president of International Business and Investor Relations, and now serves as chief international business officer, chairman of the Intercontinental Cardiac Rhythm Management Committee, and a member of the Intercontinental Orthopedics Executive Committee at MicroPort®. Jonathan has been chairman of Endovastec™ since November 2023.
About us
News
Products
Investor Relations
Telephone:(86) (21) 38139300
Address:Building #1,3399 Kangxin Rd., SIMZ Century Medicine Park, Shanghai201318,P.R. China
Fax:(86) (21) 33750026
©Copyright 1998-2020, Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.
Internet Drug Information Service Qualification Certificate No.: (Hu) - Non-operating -2020-0065
Website record/ license No.： 
The registered trademarks of “微创", "MicroPort" and"
" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd., they have been authorized to be used by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.
